• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
98% Bifida Ferment Lysate
rhSOD (cosmetic grade)
Recombinant humanized collagen
Recombinant Humanized Small-molecule Collagen
Recombinant Humanized Small-molecule Collagen Solution
rhSOD

Argentina announces COVID-19 vaccine supply deal with Moderna

firstwordpharmaJuly 09, 2021

Tag: Moderna , COVID-19 , Vaccine

Argentina says it will sign a COVID-19 vaccine supply agreement with Moderna, as the country attempts to ramp up the inoculation of its population and avoid a possible third wave of coronavirus infections, reported the Financial Post.

Argentina announces COVID-19 vaccine supply deal with Moderna

Cabinet chief Santiago Cafiero said a deal would be signed with Moderna on Monday, but did not detail the number of doses being bought or the agreed delivery dates.

Argentina has so far largely built its COVID-19 inoculation program around Russia's Sputnik V vaccine, China's Sinopharm vaccine and AstraZeneca's vaccine.


Previous:Venezuela payment to COVAX received after funds blocked - Gavi

Next:Xilis Raises $70 Million Series A Financing to Advance Diagnostic and Drug Discovery and Development Platform Leveraging Proprietary MicroOrganoSphere Technology

Related News

Prenetics' IM8 Announces Collaboration with Mayo Clinic to Develop New Line of Premium Supplements

PRNewswireDecember 19, 2024

A New Premium Supplements Brand, Launched Officially on November 18th on IM8health.com

PeproMene Bio, Inc. and the Institute for Follicular Lymphoma Innovation Announce $11M Investment to Advance PMB-CT01 (BAFF-R CAR T cell therapy) for Relapsed/Refractory Follicular Lymphoma

PRNewswireDecember 19, 2024

Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration

PRNewswireDecember 20, 2024

Argentina announces COVID-19 vaccine supply deal with Moderna | Pharmasources.com

Corvia Medical Achieves CE Certification for Atrial Shunt Under New EU MDR Standards

PRNewswireDecember 21, 2024

Corvia Medical, Inc.announced today that it has achieved CE certification for the Corvia® Atrial Shunt System under the latest EU Medical Device Regulations (EU MDR 2017/745).

You may like
More>>

Rabies Vaccine(Human Diploid Cell)

Rabies Vaccine(Human Diploid Cell)
Freeze-Dried Live Attenuated Varicella Vaccine

Freeze-Dried Live Attenuated Varicella Vaccine
Varicella Vaccine,Live (Vial)

Varicella Vaccine,Live (Vial)
Influenza Vaccine(Split Virion),Inactivated

Influenza Vaccine(Split Virion),Inactivated
IPV(Inactivated Poliovirus Vaccine)

IPV(Inactivated Poliovirus Vaccine)
Meningococcal Conjugate Vaccine (Group A+C), Freeze Dried

Meningococcal Conjugate Vaccine (Group A+C), Freeze Dried
OPV(Poliomyelitis(Live)Vaccine(Monkey Kidney Cell).Oral

OPV(Poliomyelitis(Live)Vaccine(Monkey Kidney Cell).Oral
Animal Vaccine Filling Line

Animal Vaccine Filling Line
Pet Vaccine Series

Pet Vaccine Series
Poultry Vaccine Series

Poultry Vaccine Series

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service